The U.S. could see another 200,000 coronavirus deaths in the next three months if people don’t take mitigation measures such as mask-wearing and physical distancing seriously, according to the head of the Centers for Disease Control and Prevention (CDC).

“The reality is December and January and February are going to be rough times. I actually believe they’re going to be the most difficult time in the public health history of this nation,” largely because of the stress to the health system, CDC Director Robert Redfield said Wednesday during a U.S. Chamber of Commerce event.

The coronavirus is surging across the entire nation, and the health care system is being strained nearly to the breaking point in many states. At least 270,000 people have died, including nearly 2,600 on Tuesday, the highest single-day death toll of the pandemic so far.

Redfield said 90 percent of hospitals are in the red zone, 

Here we are, still living through this damn zombie movie. Only the zombies aren’t the living dead; they’re the incompetent braindead in living bodies, jerkily animated by their own impervious wants, sightless and hollowed out, incapable of self-preservation yet wreakers of havoc and destruction on others. It took just one zombie on the Baltimore Ravens who neglected to cover his nose and mouth with a mask to thereby wreck his own team, and with a ripple effect of infection plunge the NFL into organizational chaos.

© Patrick Smith/Getty Images
Coaches such as Baltimore’s John Harbaugh will wear masks during games. (Patrick Smith/Getty Images)

They’re easy to spot, zombies: They’re the un-sentient, disconnected husks who walk around breathing potential hell on their colleagues and neighbors. They lurch clumsily into the midst of crowded rooms with their masks either missing or dragging around their chins, spreading their odorless danger mercilessly as they

The Texas doctor captured on film cradling a distraught Covid-19 patient on Thanksgiving has spoken of the sad isolation of his elderly patients and pleaded with people to “do the basic things” to avoid infection and stay out of hospital.

© Go Nakamura/Getty Images
HOUSTON, TX – NOVEMBER 26: (EDITORIAL USE ONLY) Dr. Joseph Varon hugs and comforts a patient in the COVID-19 intensive care unit (ICU) during Thanksgiving at the United Memorial Medical Center on November 26, 2020 in Houston, Texas. According to reports, Texas has reached over 1,220,000 cases, including over 21,500 deaths. (Photo by Go Nakamura/Getty Images)

Hospitalizations from Covid-19 reached another record high across the US Monday, with officials across several states expressing concern that health care facilities would be overwhelmed.

Dr. Joseph Varon, chief of staff at United Memorial Medical Center in Houston, told CNN’s New Day on Monday that he had worked for

PEople should exercise restraint in going out as the Covid cases are rising. Contrary to this, markets in Solan are witnessing huge crowds throughout the day. Mall Road registers the maximum influx of vehicles, including three-wheelers, and pedestrians have little space to maintain social distancing. Residents should themselves be responsible to restrict their outings instead of expecting the government to impose another lockdown. — Balram, solan

Health Minister should have done surprise inspection

THE long-delayed visit of the Health Minister to the IGMC Covid ward is nothing more than an eyewash and a damage-control exercise. Things could have been different if it was a surprise inspection. Since the visit was planned, the IGMC authorities would have placed things in order. How can a patient admitted to the ward, who is at the mercy of doctors and paramedical staff, speak against them? Everyone knows the reality of Covid patients, but for

The Los Angeles County public health director on Saturday warned residents that they “need to not gather with anyone not in our immediate household” as COVID-19 cases have surged and the holiday season continues. New restrictions for the county, the strictest in the state of California, are set to go into effect on Monday, November 30 and last until December 20. 

“I understand everyone’s frustration, but we are headed into the holiday season and more than anything we are longing to spend time with our friends and family,” said Los Angeles County Public Health director Barbara Ferrer. “If we really care about each other and we care about those essential workers taking risks everyday to make sure we have food, water, healthcare and needed services, we need to not gather with people not in our immediate household, at least for the immediate future.”

The new restrictions prohibit most public

Montreal, Canada – ( NewMediaWire ) – November 27, 2020 – Vision Marine Technologies Inc. (Nasdaq: VMAR), the leading provider of electric technology in the design and manufacture of the first fully electric powertrain outboard motor (E-Motion) and electric power boats, today announced the closing of its initial public offering of 2,760,000 common shares at a price of US$10.00 per share, which includes 360,000 shares sold upon full exercise of the underwriter’s option to purchase additional common shares. The gross proceeds from the offering, including the exercise of the over-allotment option, were US$27,600,000, before deducting underwriting discounts, commissions and offering expenses. 

ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering.  

Vision intends to use the net proceeds from the offering for sales and marketing, build-up of inventory for order fulfillment, research and development, development of rental operations, and general working capital.

A registration

SINGAPORE–(BUSINESS WIRE)–Nov 27, 2020–

Tiga Acquisition Corp. (the “Company”) (NYSE: TINV.U) today announced the closing of its initial public offering of 27,600,000 units, which includes 3,600,000 units issued upon the exercise of the underwriters’ overallotment option, which was exercised in full, at a public offering price of $10.00 per unit, resulting in gross proceeds of $276 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. The units began trading on the NYSE under the symbol “TINV.U” on November 24, 2020. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols “TINV” and “TINV WS,” respectively.

The Company is led

SAN DIEGO, Nov. 24, 2020 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of its initial public offering of 69,000,000 shares of Class A common stock, including the full exercise of the underwriters’ option to purchase up to 9,000,000 additional shares of Class A common stock, at a public offering price of $27 per share. The aggregate gross proceeds to Maravai from the offering were approximately $1,863,000,000, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Maravai. Maravai’s Class A common stock began trading on the Nasdaq Global Select Market on November 20, 2020 under the symbol “MRVI.”

Morgan Stanley, Jefferies and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering. BofA Securities,

The MarketWatch News Department was not involved in the creation of this content.

November 24, 2020 (ACCESSWIRE via COMTEX) —
Not for distribution to U.S. news wire services or dissemination in the United States.

VANCOUVER, BC / ACCESSWIRE / November 24, 2020 / Silver Elephant Mining Corp. (“Silver Elephant” or the “Company”) (TSX:ELEF)(OTCQX:SILEF)(Frankfurt:1P2N) is pleased to announce the closing of its bought deal short form prospectus offering pursuant to which the Company has issued 23,000,000 common shares of the Company (the “Common Shares”) at a price of C$0.40 per Common Share, for aggregate gross proceeds of C$9,200,000 (the “Offering”), including the full exercise of the over-allotment option.

The MarketWatch News Department was not involved in the creation of this content.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the closing of its underwritten public offering of 2,875,000 shares of its common stock, including 375,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $39.00 per share. The net proceeds from the offering were approximately $105.1 million, after deducting underwriting discounts and commissions and estimated offering expenses.